Rigel Pharmaceuticals Inc (RIGL) insider trading
Every open-market stock purchase and sale by Rigel Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $306K over the last 12 months (3 sales). No open-market buys.
- Last insider buy: Raul R Rodriguez (CEO), $688K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $306K (3 sales). Last close $48.86 on Oct 22, 2026.
Recent RIGL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | $48.4K |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | $31.1K |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | $11.6K |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | $8.8K |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | — |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | — |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | — |
| Sep 2, 2026 | Dean L Schorno (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Raul R Rodriguez (CEO) | Sold (not open market) | $115K |
| Sep 1, 2026 | Dean L Schorno (CFO) | Sold (not open market) | $44.1K |
| Sep 1, 2026 | Raymond J. Furey (C-suite exec) | Sold (not open market) | $41.7K |
| Sep 1, 2026 | David A Santos (C-suite exec) | Sold (not open market) | $41.5K |
| Jul 8, 2026 | Alison L. Hannah (C-suite exec) | Bought (not open market) | — |
| Jun 22, 2026 | Kamil Ali-Jackson (Insider) | Sold | $87.5K |
| Jun 17, 2026 | Lisa Rojkjaer (C-suite exec) | Bought (not open market) | — |
| Jun 17, 2026 | Raymond J. Furey (C-suite exec) | Bought (not open market) | — |
| Jun 17, 2026 | David A Santos (C-suite exec) | Bought (not open market) | — |
| Jun 17, 2026 | Lisa Rojkjaer (C-suite exec) | Bought (not open market) | — |
| Jun 17, 2026 | Raul R Rodriguez (CEO) | Bought (not open market) | — |
| Jun 17, 2026 | Dean L Schorno (CFO) | Bought (not open market) | — |
| Jun 1, 2026 | Raul R Rodriguez (CEO) | Sold (not open market) | $72.4K |
| Jun 1, 2026 | Dean L Schorno (CFO) | Sold (not open market) | $27.7K |
| Jun 1, 2026 | Raymond J. Furey (C-suite exec) | Sold (not open market) | $26.2K |
| Jun 1, 2026 | David A Santos (C-suite exec) | Sold (not open market) | $26.1K |
| Jun 1, 2026 | Lisa Rojkjaer (C-suite exec) | Sold (not open market) | $25.4K |
Who's trading RIGL
- Dean L Schorno, CFO: other filings, last Sep 2, 2026
- Raul R Rodriguez, CEO: other filings, last Sep 1, 2026
- David A Santos, C-suite exec: other filings, last Sep 1, 2026
- Raymond J. Furey, C-suite exec: other filings, last Sep 1, 2026
- Alison L. Hannah, Insider: other filings, last Jul 8, 2026
- Kamil Ali-Jackson, Insider: sold $160K (2 sales), last Jun 22, 2026
- Lisa Rojkjaer, C-suite exec: other filings, last Jun 17, 2026
- Jane Wasman, Insider: other filings, last May 15, 2026
- Mark W Frohlich, Insider: other filings, last May 15, 2026
- Anthony Gregg Lapointe, Insider: other filings, last May 15, 2026
- Michael Patrick Miller, Insider: other filings, last May 15, 2026
- Walter H Moos, Insider: sold $145K (1 sale), last May 15, 2026
Get free alerts when an insider at Rigel Pharmaceuticals Inc files a new trade →